Mirum Pharmaceuticals (MIRM) Shareholder's Equity (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Mirum Pharmaceuticals | 5.97 Bn | 5.59 Bn | 131.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.94% |
| Dec 31, 2025 | 7.75% |
| Sep 30, 2025 | 14.46% |
| Jun 30, 2025 | 9.39% |
| Mar 31, 2025 | 3.38% |
| Dec 31, 2024 | -2.75% |
| Sep 30, 2024 | 1.33% |
| Jun 30, 2024 | -2.39% |
| Mar 31, 2024 | -5.66% |
| Dec 31, 2023 | -7.59% |
| Sep 30, 2023 | 242.30% |
| Jun 30, 2023 | -44.31% |
| Mar 31, 2023 | -0.62% |
| Dec 31, 2022 | -16.10% |
| Sep 30, 2022 | 52.95% |
| Jun 30, 2022 | 1.61% |
| Mar 31, 2022 | -9.38% |
| Dec 31, 2021 | 113.16% |
| Sep 30, 2021 | -41.09% |
| Jun 30, 2021 | -28.49% |
| Mar 31, 2021 | -22.20% |
| Dec 31, 2020 | 43.11% |
| Sep 30, 2020 | -11.71% |
| Jun 30, 2020 | -12.75% |
| Mar 31, 2020 | 19.77% |
| Dec 31, 2019 | -10.84% |
| Sep 30, 2019 | 518.44% |
| Jun 30, 2019 | -51.57% |
| Mar 31, 2019 | -33.15% |